😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Canopy Growth director Willy Kruh sells $37k in shares

Published 2024-06-12, 08:52 p/m
CGC
-

In a recent move that caught the attention of market watchers, Willy Kruh, a director at Canopy Growth Corp (NYSE:NASDAQ:CGC), sold a portion of his holdings in the company. The transaction, which took place on June 10, 2024, involved the sale of 3,738 common shares at an average price of $9.94 CAD per share, amounting to a total of $37,155 CAD.

The sale was disclosed in a regulatory filing with the U.S. Securities and Exchange Commission (SEC). According to the details of the filing, the shares disposed of by Kruh were initially granted as restricted stock units (RSUs). The disposal is understood to be related to the tax obligations arising from the vesting of these RSUs.

In addition to the sale, the filing also mentioned the acquisition of 14,360 common shares by Kruh on the same date. These shares, granted in the form of RSUs, have a vesting schedule that includes four equal installments on the following dates: June 28, 2024, September 30, 2024, December 31, 2024, and March 31, 2025. Notably, these shares were reported to have a transactional value of $0.0 CAD, suggesting they were granted to the director without cost.

After the reported transactions, Kruh's ownership in Canopy Growth Corp (TSX:WEED) stands at 17,295 shares. The recent filings give a clearer picture of the insider trading activity within the company and provide investors with insights into the stock transactions of its directors.

Canopy Growth Corp, listed on the New York Stock Exchange under the ticker NYSE:CGC, operates in the medicinal chemicals and botanical products industry. The company's business address is located at 1 Hershey Drive, Smiths Falls, Ontario.

In other recent news, Canopy Growth Corporation has been making significant strides in its business development. The company recently finalized the acquisition of Jetty and two Wana Brands business units via its subsidiary, Canopy USA. This move is aimed at strengthening Canopy Growth's presence in the cannabis market. In addition to these acquisitions, the company also purchased a significant portion of Acreage Holdings (OTC:ACRGF), Inc.'s debt.

Further acquisitions are in the pipeline, including the pending acquisition of Acreage's Fixed Shares and Floating Shares by Canopy USA, and the anticipated acquisition of Mountain High Products, LLC, expected to close in the first half of fiscal 2025. In terms of financial performance, Canopy Growth reported a 16% year-over-year increase in consolidated net revenue, reaching $73 million in Q4 FY24, and reduced its debt by over $700 million.

Analysts from Piper Sandler and Roth/MKM have reviewed Canopy Growth's performance, maintaining their Underweight and Buy ratings respectively, but adjusting future sales forecasts. These reviews suggest a cautious yet hopeful outlook for the company, especially with the potential benefits from the federal rescheduling of cannabis. Canopy Growth remains committed to product innovation and social equity within the cannabis sector, with these recent developments expected to contribute to its growth.

InvestingPro Insights

As investors digest the recent insider trading activity at Canopy Growth Corp (NYSE:CGC), it's important to consider the company's financial health and market performance. With a market capitalization of $578.97 million, Canopy Growth's position in the medicinal chemicals and botanical products industry is notable, yet its financial metrics suggest challenges ahead. The company's P/E ratio stands at -1.18, reflecting investor concerns about profitability, which is echoed by analysts' expectations that the company will not be profitable this year, as per InvestingPro Tips.

InvestingPro Data indicates a revenue decline of 10.83% over the last twelve months as of Q4 2024, which may raise questions about the company's growth trajectory. However, a quarterly revenue growth of 6.67% in Q4 2024 shows some positive momentum. The stock's recent price volatility is also noteworthy, with a significant three-month total return of 156.42%, yet a one-month total return showing a decline of 19.08%. This high price volatility is a key point for investors to consider, as highlighted in InvestingPro Tips.

For those looking to delve deeper into Canopy Growth's performance and prospects, additional insights are available on InvestingPro, with a total of 9 InvestingPro Tips that can help investors make more informed decisions. To access these insights, visit https://www.investing.com/pro/CGC and remember to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.